Literature DB >> 17944028

Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production.

Alexandr Parlesak1, Simone Schaeckeler, Lydia Moser, Christiane Bode.   

Abstract

OBJECTIVE: Endotoxemia was shown to be integral in the pathophysiology of obstructive jaundice. In the current study, the role of conjugated primary bile salts (CPBS) and phosphatidylcholine on the permeability of endotoxin through a layer of intestinal epithelial cells and the consequent activation of basolaterally cocultured human mononuclear leukocytes were measured.
DESIGN: In a coculture model, a layer of differentiated, confluent Caco-2 cells was apically stimulated with growth-arrested, nonpathogenic Escherichia coli.
SETTING: Basic human cell culture laboratory.
INTERVENTIONS: The effect of CPBS (0.5 mM and 1.5 mM), phosphatidylcholine (0.38 mM), and human bile (0.5% vol/vol) on the barrier function was assessed by the measurement of transepithelial electrical resistance, by endotoxin permeability through the intestinal epithelial cell layer, and by basolateral cytokine enzyme-linked immunosorbent assay measurement (tumor necrosis factor-[alpha], interleukins-6, -8, and -10). Micelles formed by CPBS were detected by dynamic light scattering. The association of endotoxin with CPBS micelles was tested by fluorescence resonance energy transfer.
MEASUREMENTS AND MAIN RESULTS: Apical addition of CPBS suppressed the permeability of endotoxins through the intestinal epithelial cell layer significantly. In parallel, apical supplementation of CPBS dose-dependently reduced the basolateral production of all cytokines measured. Apical phosphatidylcholine supplementation enhanced this effect significantly. CPBS formed micelles (diameter, 134 +/- 7 nm), which were able to bind endotoxin to their surface.
CONCLUSIONS: CPBS can reduce the permeation of endotoxin through intestinal epithelial cell layers by binding it to micelles. Thereby, the inflammatory processes beyond the mucosal surface are suppressed, an effect that is enhanced by phosphatidylcholine. (C) 2007 Lippincott Williams & Wilkins, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17944028     DOI: 10.1097/01.ccm.0000284586.84952.fb

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

Review 1.  Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.

Authors:  Fabiana de Faria Ghetti; Daiane Gonçalves Oliveira; Juliano Machado de Oliveira; Lincoln Eduardo Villela Vieira de Castro Ferreira; Dionéia Evangelista Cesar; Ana Paula Boroni Moreira
Journal:  Eur J Nutr       Date:  2017-09-05       Impact factor: 5.614

2.  Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.

Authors:  Valentina Volynets; Astrid Spruss; Giridhar Kanuri; Sabine Wagnerberger; Stephan C Bischoff; Ina Bergheim
Journal:  J Lipid Res       Date:  2010-09-16       Impact factor: 5.922

Review 3.  Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.

Authors:  Hannah Schneider; Annika Braun; Joachim Füllekrug; Wolfgang Stremmel; Robert Ehehalt
Journal:  Int J Mol Sci       Date:  2010-10-25       Impact factor: 5.923

4.  TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells.

Authors:  Irina Treede; Annika Braun; Petia Jeliaskova; Thomas Giese; Joachim Füllekrug; Gareth Griffiths; Wolfgang Stremmel; Robert Ehehalt
Journal:  BMC Gastroenterol       Date:  2009-07-13       Impact factor: 3.067

5.  Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations.

Authors:  Laimdota Zizmare; Christina N Boyle; Sabrina Buss; Sandrine Louis; Laura Kuebler; Ketki Mulay; Ralf Krüger; Lara Steinhauer; Isabelle Mack; Manuel Rodriguez Gomez; Kristina Herfert; Yvonne Ritze; Christoph Trautwein
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.